An International, Multicentre, Prospective, Single-Arm Study to Assess the Effect on Voluntary Movements of AbobotulinumtoxinA 1500 U Administered in Both Upper and Lower Limbs in Conjunction With a Guided Self-Rehabilitation Contract in Adult Subjects With Spastic Hemiparesis
Latest Information Update: 15 Jul 2020
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Paresis
- Focus Therapeutic Use
- Acronyms ENGAGE
- Sponsors Ipsen
- 23 Sep 2019 Results presented in an Ipsen media release.
- 23 Sep 2019 According to an Ipsen media release, Professor Jean-Michel Gracies, Professor and Chair in the Department of Neurorehabilitation at Hospital Henri Mondor, in Creteil, France, is the primary investigator of the trial.
- 23 Sep 2019 Results presented in an Ipsen media release.